ENTITY
Bloomage Biotechnology

Bloomage Biotechnology (963 HK)

30
Analysis
Materials • China
Bloomage Biotechnology is a global biotechnology and biomaterial company specializing in the research, development, production, and application of bioactive substances, primarily hyaluronic acid and its derivatives. These products serve the pharmaceuticals, medical devices, cosmetics, and food/nutrition industries. The company was founded in 2000 and is headquartered in Jinan, Shandong, China.
more
bullish•Honasa Consumer
•07 Nov 2023 09:55

Honasa Consumer IPO Trading - Great Anchor Book, Not so Great Overall Demand. Loved by FIIs

Honasa Consumer (Honasa IN) raised about US$200m in its India IPO. In this note, we talk about the deal updates and the trading dynamics.

Logo
556 Views
Share
bullish•Honasa Consumer
•30 Oct 2023 11:25

Honasa Consumer IPO - Thoughts on Valuations

Honasa Consumer, a beauty and personal care company, is looking to raise about US$200m in its upcoming India IPO. In this note we talk about...

Logo
604 Views
Share
bullish•Honasa Consumer
•27 Oct 2023 09:56

Honasa Consumer IPO - RHP Updates - Sales Strong, Slight Margin Improvement

Honasa Consumer (HC) is looking to raise about US$200m in its upcoming India IPO. In this note, we talk about updates from its recent filings.

Logo
756 Views
Share
bearish•Giant Biogene
•02 May 2023 09:57

Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x

Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...

Logo
686 Views
Share
bullish•Giant Biogene
•03 Nov 2022 09:50

Giant Biogene IPO Trading - Demand Was Relatively Better but Still Weak

Giant Biogene (GB) raised around US$70m by pricing its  HK IPO at the low-end. In this note we talk about the trading dynamics.

Logo
474 Views
Share
x